APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perfluorocarbon-based Ultrasound Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Perfluorocarbon-based Ultrasound Contrast Agents Market Analysis and Forecast 2026-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchPerfluorocarbon-based Ultrasound Contrast Agents Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Perfluorocarbon-based Ultrasound Contrast Agents Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Perfluorocarbon-based Ultrasound Contrast Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents include Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Feiruida Medical, Fuman Group, Lizhuo Pharmaceutical and Qi-hui Biopharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Perfluorocarbon-based Ultrasound Contrast Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Perfluorocarbon-based Ultrasound Contrast Agents, also provides the sales of main regions and countries. Of the upcoming market potential for Perfluorocarbon-based Ultrasound Contrast Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Perfluorocarbon-based Ultrasound Contrast Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Perfluorocarbon-based Ultrasound Contrast Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Perfluorocarbon-based Ultrasound Contrast Agents sales, projected growth trends, production technology, application and end-user industry.

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Company

Bracco

GE Healthcare

ImaRx Therapeutics

Lantheus Medical Imaging

Microvascular Therapeutics

Feiruida Medical

Fuman Group

Lizhuo Pharmaceutical

Qi-hui Biopharmaceutical

SUNΛ Med-Engineering

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Type

Perfluorobutane

Perfluoropropane

Sulfur Hexafluoride

Others

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Application

Liver Ultrasonography

Cardiac Ultrasonography

Angiographic Ultrasonography

Others

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perfluorocarbon-based Ultrasound Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perfluorocarbon-based Ultrasound Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perfluorocarbon-based Ultrasound Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Perfluorocarbon-based Ultrasound Contrast Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Perfluorocarbon-based Ultrasound Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Perfluorocarbon-based Ultrasound Contrast Agents sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Perfluorobutane Major Manufacturers Table 3. Perfluoropropane Major Manufacturers Table 4. Sulfur Hexafluoride Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Liver Ultrasonography Major Manufacturers Table 8. Cardiac Ultrasonography Major Manufacturers Table 9. Angiographic Ultrasonography Major Manufacturers Table 10. Others Major Manufacturers Table 11. Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends Table 12. Perfluorocarbon-based Ultrasound Contrast Agents Industry Drivers Table 13. Perfluorocarbon-based Ultrasound Contrast Agents Industry Opportunities and Challenges Table 14. Perfluorocarbon-based Ultrasound Contrast Agents Industry Restraints Table 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2021-2026) Table 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2027-2032) Table 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026) & (Units) Table 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2027-2032) & (Units) Table 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2021-2026) Table 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2027-2032) Table 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Manufacturers (2021-2026) Table 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers, Product Type & Application Table 33. Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2026) Table 40. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2027-2032) Table 41. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type 2021 VS 2025 VS 2032 (Units) Table 42. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units) Table 43. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2027-2032) & (Units) Table 44. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026) Table 45. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2027-2032) Table 46. Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2021-2026) & (US$/Unit) Table 47. Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2027-2032) & (US$/Unit) Table 48. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2026) Table 52. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2027-2032) Table 53. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application 2021 VS 2025 VS 2032 (Units) Table 54. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units) Table 55. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2027-2032) & (Units) Table 56. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026) Table 57. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2027-2032) Table 58. Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2021-2026) & (US$/Unit) Table 59. Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2027-2032) & (US$/Unit) Table 60. Bracco Company Information Table 61. Bracco Business Overview Table 62. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 64. Bracco Recent Development Table 65. GE Healthcare Company Information Table 66. GE Healthcare Business Overview Table 67. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 69. GE Healthcare Recent Development Table 70. ImaRx Therapeutics Company Information Table 71. ImaRx Therapeutics Business Overview Table 72. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 74. ImaRx Therapeutics Recent Development Table 75. Lantheus Medical Imaging Company Information Table 76. Lantheus Medical Imaging Business Overview Table 77. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 79. Lantheus Medical Imaging Recent Development Table 80. Microvascular Therapeutics Company Information Table 81. Microvascular Therapeutics Business Overview Table 82. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 84. Microvascular Therapeutics Recent Development Table 85. Feiruida Medical Company Information Table 86. Feiruida Medical Business Overview Table 87. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 89. Feiruida Medical Recent Development Table 90. Fuman Group Company Information Table 91. Fuman Group Business Overview Table 92. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 94. Fuman Group Recent Development Table 95. Lizhuo Pharmaceutical Company Information Table 96. Lizhuo Pharmaceutical Business Overview Table 97. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 99. Lizhuo Pharmaceutical Recent Development Table 100. Qi-hui Biopharmaceutical Company Information Table 101. Qi-hui Biopharmaceutical Business Overview Table 102. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 104. Qi-hui Biopharmaceutical Recent Development Table 105. SUNΛ Med-Engineering Company Information Table 106. SUNΛ Med-Engineering Business Overview Table 107. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 109. SUNΛ Med-Engineering Recent Development Table 110. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units) Table 113. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2027-2032) & (Units) Table 114. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 115. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 116. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 117. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 118. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units) Table 119. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2027-2032) & (Units) Table 120. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 121. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 122. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 126. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 127. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 128. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 129. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 130. United States Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 131. Canada Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 132. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 133. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units) Table 136. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2027-2032) & (Units) Table 137. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units) Table 142. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2027-2032) & (Units) Table 143. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 149. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 150. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 151. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Germany Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 154. France Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 155. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 156. Italy Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 157. Russia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 158. Spain Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 159. Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 160. Switzerland Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 161. Sweden Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 162. Poland Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 163. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 164. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 165. China Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units) Table 166. China Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2027-2032) & (Units) Table 167. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 168. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 169. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 170. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 171. China Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units) Table 172. China Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2027-2032) & (Units) Table 173. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 174. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 176. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 177. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units) Table 178. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2027-2032) & (Units) Table 179. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 180. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 181. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 182. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 183. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units) Table 184. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2027-2032) & (Units) Table 185. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 186. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 191. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 192. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 193. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 194. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Japan Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 196. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 197. India Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 198. Australia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 199. Taiwan Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 200. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 201. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 202. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 203. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units) Table 204. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2027-2032) & (Units) Table 205. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 206. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 207. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 208. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 209. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units) Table 210. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2027-2032) & (Units) Table 211. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 212. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 213. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 217. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 218. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 219. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 220. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 221. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 222. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 223. Chile Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 224. Colombia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 225. Peru Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 226. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 227. Israel Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 228. UAE Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 229. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 230. Iran Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 231. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Table 232. Key Raw Materials Table 233. Raw Materials Key Suppliers Table 234. Perfluorocarbon-based Ultrasound Contrast Agents Distributors List Table 235. Perfluorocarbon-based Ultrasound Contrast Agents Customers List Table 236. Research Programs/Design for This Report Table 237. Authors List of This Report Table 238. Secondary Sources Table 239. Primary Sources List of Figures Figure 1. Perfluorocarbon-based Ultrasound Contrast Agents Image Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Share 2021 VS 2025 VS 2032 Figure 4. Perfluorobutane Image Figure 5. Perfluoropropane Image Figure 6. Sulfur Hexafluoride Image Figure 7. Others Image Figure 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Share 2021 VS 2025 VS 2032 Figure 10. Liver Ultrasonography Image Figure 11. Cardiac Ultrasonography Image Figure 12. Angiographic Ultrasonography Image Figure 13. Others Image Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2021-2032) Figure 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (2021-2032) & (Units) Figure 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2021-2032) & (Units) Figure 23. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2021-2032) & (Units) Figure 24. China Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2021-2032) & (Units) Figure 25. Asia (Excluding China) Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2021-2032) & (Units) Figure 26. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales YoY (2021-2032) & (Units) Figure 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2032) Figure 33. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 34. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2032) Figure 36. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2032) Figure 39. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 40. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2032) Figure 42. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Type (2021-2032) Figure 43. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Type (2021-2032) Figure 44. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Application (2021-2032) Figure 45. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Application (2021-2032) Figure 46. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country (2021-2032) Figure 47. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Country (2021-2032) Figure 48. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Type (2021-2032) Figure 49. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Type (2021-2032) Figure 50. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Application (2021-2032) Figure 51. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Application (2021-2032) Figure 52. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country (2021-2032) Figure 53. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Country (2021-2032) Figure 54. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Type (2021-2032) Figure 55. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Type (2021-2032) Figure 56. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Application (2021-2032) Figure 57. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Application (2021-2032) Figure 58. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Type (2021-2032) Figure 59. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Type (2021-2032) Figure 60. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Application (2021-2032) Figure 61. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Application (2021-2032) Figure 62. Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country (2021-2032) Figure 63. Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Country (2021-2032) Figure 64. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Type (2021-2032) Figure 65. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Type (2021-2032) Figure 66. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Application (2021-2032) Figure 67. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Application (2021-2032) Figure 68. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country (2021-2032) Figure 69. SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Country (2021-2032) Figure 70. Perfluorocarbon-based Ultrasound Contrast Agents Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Perfluorocarbon-based Ultrasound Contrast Agents Production Mode & Proce

Scope & coverage.

Types
  • Perfluorobutane
  • Perfluoropropane
  • Sulfur Hexafluoride
  • Others
Applications
  • Liver Ultrasonography
  • Cardiac Ultrasonography
  • Angiographic Ultrasonography
  • Others
Companies covered
  • Bracco
  • GE Healthcare
  • ImaRx Therapeutics
  • Lantheus Medical Imaging
  • Microvascular Therapeutics
  • Feiruida Medical
  • Fuman Group
  • Lizhuo Pharmaceutical
  • Qi-hui Biopharmaceutical
  • SUNΛ Med-Engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Perfluorocarbon-based Ultrasound Contrast Agents Market by Type
  3. 1.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Perfluorobutane
  5. 1.2.3 Perfluoropropane
  6. 1.2.4 Sulfur Hexafluoride
  7. 1.2.5 Others
  8. 1.3 Perfluorocarbon-based Ultrasound Contrast Agents Market by Application
  9. 1.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Liver Ultrasonography
  11. 1.3.3 Cardiac Ultrasonography
  12. 1.3.4 Angiographic Ultrasonography
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Perfluorocarbon-based Ultrasound Contrast Agents Market Dynamics
  1. 2.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends
  2. 2.2 Perfluorocarbon-based Ultrasound Contrast Agents Industry Drivers
  3. 2.3 Perfluorocarbon-based Ultrasound Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Perfluorocarbon-based Ultrasound Contrast Agents Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region
  3. 3.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026)
  5. 3.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2027-2032)
  6. 3.2.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region
  9. 3.4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026)
  11. 3.4.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2027-2032)
  12. 3.4.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers
  2. 4.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers
  6. 4.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers, Product Type & Application
  13. 4.7 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market CR5 and HHI
  16. 4.8.2 2025 Perfluorocarbon-based Ultrasound Contrast Agents Tier 1, Tier 2, and Tier 3
5 Perfluorocarbon-based Ultrasound Contrast Agents Market by Type
  1. 5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type
  2. 5.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type
  6. 5.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2032)
  9. 5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Type
6 Perfluorocarbon-based Ultrasound Contrast Agents Market by Application
  1. 6.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application
  2. 6.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application
  6. 6.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2032)
  9. 6.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Application
7 Company Profiles
  1. 7.1 Bracco
  2. 7.1.1 Bracco Company Information
  3. 7.1.2 Bracco Business Overview
  4. 7.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  6. 7.1.5 Bracco Recent Developments
  7. 7.2 GE Healthcare
  8. 7.2.1 GE Healthcare Company Information
  9. 7.2.2 GE Healthcare Business Overview
  10. 7.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  12. 7.2.5 GE Healthcare Recent Developments
  13. 7.3 ImaRx Therapeutics
  14. 7.3.1 ImaRx Therapeutics Company Information
  15. 7.3.2 ImaRx Therapeutics Business Overview
  16. 7.3.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  18. 7.3.5 ImaRx Therapeutics Recent Developments
  19. 7.4 Lantheus Medical Imaging
  20. 7.4.1 Lantheus Medical Imaging Company Information
  21. 7.4.2 Lantheus Medical Imaging Business Overview
  22. 7.4.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  24. 7.4.5 Lantheus Medical Imaging Recent Developments
  25. 7.5 Microvascular Therapeutics
  26. 7.5.1 Microvascular Therapeutics Company Information
  27. 7.5.2 Microvascular Therapeutics Business Overview
  28. 7.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  30. 7.5.5 Microvascular Therapeutics Recent Developments
  31. 7.6 Feiruida Medical
  32. 7.6.1 Feiruida Medical Company Information
  33. 7.6.2 Feiruida Medical Business Overview
  34. 7.6.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  36. 7.6.5 Feiruida Medical Recent Developments
  37. 7.7 Fuman Group
  38. 7.7.1 Fuman Group Company Information
  39. 7.7.2 Fuman Group Business Overview
  40. 7.7.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  42. 7.7.5 Fuman Group Recent Developments
  43. 7.8 Lizhuo Pharmaceutical
  44. 7.8.1 Lizhuo Pharmaceutical Company Information
  45. 7.8.2 Lizhuo Pharmaceutical Business Overview
  46. 7.8.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  48. 7.8.5 Lizhuo Pharmaceutical Recent Developments
  49. 7.9 Qi-hui Biopharmaceutical
  50. 7.9.1 Qi-hui Biopharmaceutical Company Information
  51. 7.9.2 Qi-hui Biopharmaceutical Business Overview
  52. 7.9.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  54. 7.9.5 Qi-hui Biopharmaceutical Recent Developments
  55. 7.10 SUNΛ Med-Engineering
  56. 7.10.1 SUNΛ Med-Engineering Company Information
  57. 7.10.2 SUNΛ Med-Engineering Business Overview
  58. 7.10.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  60. 7.10.5 SUNΛ Med-Engineering Recent Developments
8 North America
  1. 8.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type
  2. 8.1.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2032)
  3. 8.1.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2032)
  4. 8.1.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2021-2032)
  5. 8.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application
  6. 8.2.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2032)
  7. 8.2.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2032)
  8. 8.2.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2021-2032)
  9. 8.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
  10. 8.3.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type
  2. 9.1.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2032)
  3. 9.1.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2032)
  4. 9.1.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2021-2032)
  5. 9.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application
  6. 9.2.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2032)
  7. 9.2.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2032)
  8. 9.2.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2021-2032)
  9. 9.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
  10. 9.3.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type
  2. 10.1.1 China Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2032)
  3. 10.1.2 China Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2032)
  4. 10.1.3 China Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2021-2032)
  5. 10.2 China Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application
  6. 10.2.1 China Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2032)
  7. 10.2.2 China Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2032)
  8. 10.2.3 China Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type
  2. 11.1.1 Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2032)
  3. 11.1.2 Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2032)
  4. 11.1.3 Asia Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2021-2032)
  5. 11.2 Asia Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application
  6. 11.2.1 Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2032)
  7. 11.2.2 Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2032)
  8. 11.2.3 Asia Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2021-2032)
  9. 11.3 Asia Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
  10. 11.3.1 Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Perfluorocarbon-based Ultrasound Contrast Agents Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Type
  2. 12.1.1 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2021-2032)
  5. 12.2 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Application
  6. 12.2.1 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2021-2032)
  9. 12.3 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
  10. 12.3.1 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Perfluorocarbon-based Ultrasound Contrast Agents Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Perfluorocarbon-based Ultrasound Contrast Agents Value Chain Analysis
  2. 13.1.1 Perfluorocarbon-based Ultrasound Contrast Agents Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Perfluorocarbon-based Ultrasound Contrast Agents Production Mode & Process
  6. 13.2 Perfluorocarbon-based Ultrasound Contrast Agents Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Perfluorocarbon-based Ultrasound Contrast Agents Distributors
  9. 13.2.3 Perfluorocarbon-based Ultrasound Contrast Agents Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst